Adma Biologics | ADMA - Current Assets

Stock Price
11.26
Daily Change
0.18 1.62%
Monthly
16.93%
Yearly
-48.49%
Q2 Forecast
11.02

Adma Biologics reported $466.51M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Adma Biologics USD 466.51M 63.86M Dec/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
BioCryst Pharmaceuticals USD 404.35M 48.66M Dec/2025
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Novavax USD 978.28M 3.69M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Takeda JPY 3.12T 195.82B Dec/2025